Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Circassia Pharmaceuticals ( (GB:NIOX) ) has issued an announcement.
NIOX Group plc announced that its Chief Operating Officer, Jonathan Emms, executed a financial transaction involving the company’s shares. On December 18, 2024, Emms sold 64,885 ordinary shares and subsequently repurchased 31,604 shares into his ISA at a higher price, while his spouse, Sharon Emms, also purchased 31,604 shares. These actions have resulted in Jonathan Emms holding a total of 941,669 shares, representing 0.23% of the company’s share capital. The transactions were conducted on the London Stock Exchange’s AIM market.
More about Circassia Pharmaceuticals
YTD Price Performance: -7.08%
Average Trading Volume: 929,095
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £244M
For an in-depth examination of NIOX stock, go to TipRanks’ Stock Analysis page.
